PDCD4 and in situ carcinoma: Furthermore, the expression levels of the PDCD4 protein in the OVCAR3/CIS cells that were transfected with the miR-106a inhibitor were significantly increased compared with that of the OVCAR3/CIS cells that were transfected with the control inhibitor (P<0.05; Fig. 3B and C).